Tuesday 28 September

16:00

Registration

17:00

Ari Eliopoulos
FORTH & University of Crete Medical School, GR

Welcome

17:05

Jiri Bartek
Univerzita Palackeho, CZ

DNA damage response: Mechanisms and relevance for cancer pathogenesis and personalized treatment

17:50

Moshe Oren
Weizmann Institute, IL

Loss of p53 activity in cancer cells: the obvious and the less obvious

18:30

Varda Rotter
Weizmann Institute, IL

When mutants gain new powers: news from the mutant p53 field

19:10

Karin de Visser
Netherlands Cancer Institute, NL

The inflammatory tumor microenvironment and its impact on sporadic breast cancer development and metastasis formation

20:00

Dinner

Wednesday 29 September

09:00

Ari Eliopoulos
FORTH, & University of Crete Medical School, GR

The TNF signaling pathway: Balancing apoptosis, inflammation and cancer

09:35

Ron Apte
Ben-Gurion University, IL

The role of interleukin-1 in the malignant process

10:15

Manuela Baccarini
University of Vienna, AT

ERK signaling in inflammation and carcinogenesis

10:50

Angel Nebreda
CNIO, Madrid, ES

Signal integration by p38 MAPKs in inflammation and cancer

11:30

Coffee break & Poster Session

12:00

Manolis Pasparakis
University of Cologne, DE

The NF-κB pathway in inflammation and cancer

12:40

Jorge Caamano
University of Birmingham, UK

The Role of the Non-Canonical NF-κB Pathway in Inflammation and Cancer

13:15

George Panayotou
BSRC Al. Fleming Institute, GR

The JNK pathway in inflammation and cancer

14:00

Lunch

16:30

Curt Harris
National Cancer Institute, US

Interweaving microRNA, innate immunity and p53 networks in human cancer

17:15

Derek Mann
University of Newcastle, UK

Cellular and Molecular Conspirators in the Inflammation-Fibrosis-Cancer axis in the liver

17:55

Vassilis Gorgoulis
University of Athens, GR

Cytokines, Senescence & Cancer

18:35

Sinisa Volarevic
University of Rijeka, HR

Ribosome networks in carcinogenesis

19:15

Dimitris Kontoyiannis
BSRC Al. Fleming Institute, GR

Post-transcriptional networks in inflammation and cancer

20:00

Dinner

Thursday 30 September

09:00

Costantine Papadakis
University of Crete Medical School, GR

Dysplasia and cancer in human bowel disease

09:35

George Kollias
BSRC Al. Fleming Institute, GR

Pathogenic pathways in animal models of Inflammatory Bowel Disease

10:20

Christoph Becker
Friedrich-Alexander Universität Erlangen-Nürnberg, DE

STAT3 signalling in intestinal inflammation and cancer development

11:00

Antoine Tesniere
Paris Descartes University, FR

Cancer chemotherapy and the immune system

11:45

Coffee break & Poster Session

12:30

Chris Tsatsanis
University of Crete Medical School, GR

Molecular control of macrophage activation/ inactivation and polarization in the tumor microenvironment

13:10

Mirco Ponzoni
Genoa G Gaslini Childrens’ Hospital, IT

Tumour-targeted delivery systems for gene immunotherapy

14:00

Lunch

16:30

Dimitris Kontoyiannis
BSRC Al. Fleming Institute, GR

Transgenesis - Principles and applications

17:05

George Panayotou
BSRC Al. Fleming Institute, GR

Proteomics: Principles and applications in medical research

17:40

Stephen Moore
Almac, UK

Application of genomic technologies to inflammation and cancer research

18:15

Nicolas Goffard
Almac, UK

An integrated approach for the functional analysis of gene expression data

18:50

Vera Baumans
Utrecht University, NL

Pain and discomfort in animal models for inflammation and cancer: ethical and legislative aspects

19:25

Elengo Manoussaki
Former EC grants officer

Writing successful grant applications

19:55

Ari Eliopoulos
FORTH & University of Crete Medical School, GR

Closing remarks

20:00

Dinner